Life Sciences 2026

FRANCE Trends and Developments

Trends and Developments Contributed by: Liliana Eskenazi and Pauline Lecrenais Fréget Glaser & Associés

Fréget Glaser & Associés was founded in 2014 as a spin‑off from a leading international antitrust practice and has become a firmly established high‑end bou- tique in competition and economic regulation, with a distinctive focus on the pharmaceuticals and broader life sciences sectors. Bringing together 20 lawyers, including six partners, based in Paris and active be- fore both French and EU courts and authorities, the firm designs sophisticated, multi‑forum litigation and regulatory strategies that align closely with clients’ commercial objectives. Its team combines sharp expertise in competition, EU, public, commercial

and civil law with a granular understanding of highly regulated industries, enabling it to address complex dominance, pricing, distribution and state interven- tion issues in markets where compliance is critical to business performance. Acting for innovative pharma- ceutical and biotech companies, industry associa- tions and other health sector stakeholders, the firm handles complex investigations, high-value litigation and advisory mandates in which it actively fuses le- gal and economic analysis from the outset to secure sustainable outcomes for its clients in fast-moving markets.

Authors

Liliana Eskenazi is a partner at Fréget Glaser et Associés and an accomplished EU and competition/ antitrust lawyer with extensive experience in both advisory work and litigation. She handles complex cases

Pauline Lecrenais is an associate and at Fréget Glaser & Associés specialising in competition law and regulated sectors, with a strong focus on the healthcare and digital industries. She represents French and

before the EU and the French courts, as well as before the administrative authorities (European Commission, French Competition Authority). Well- versed in all antitrust and distribution law matters, Liliana also handles multi-jurisdictional merger control cases within the context of corporate transactions. She has developed strong expertise in regulated sectors (pharma, energy, telecoms), and in high-stakes matters where intellectual property and competition law intersect.

international companies, including major pharmaceutical players, in high-stakes competition and private enforcement cases before the French and European courts and the French Competition Authority.

Fréget Glaser & Associés 7 rue Royale 75008 Paris France Tel: +33 1 47 23 78 80 Email: contact@freget-glaser.fr Web: www.freget-glaser.fr

100 CHAMBERS.COM

Powered by